K180173

Substantially Equivalent

Freespira

Applicant: Palo Alto Health Sciences, Inc.
Product code: HCC
Advisory panel: Neurology
Date received: 2018-01-22
Decision date: 2018-08-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Kirkland, WA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.